Hightower 6M Holding’s NeoGenomics NEO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q1
– Sell
-8,670
Closed -$296K – 457
2021
Q4
$296K Sell
8,670
-284
-3% -$11.1K 0.02% 216
2021
Q3
$432K Buy
+8,954
New +$415K 0.03% 175

Other funds holding NEO

Hightower 6M Holding's NEO Position: Q1 2022 in Review

Hightower 6M Holding sold out of NeoGenomics (NEO) in Q1 2022, closing a stake of 8,670 shares — an estimated $296K sold.

Hightower 6M Holding first reported a position in NEO in Q3 2021 and held it in 2 quarters. The position peaked at $432K in Q3 2021. 278 funds tracked by Wall St. Rank hold NEO as of Q1 2022.

  • Hightower 6M Holding reported no remaining NeoGenomics position as of Q1 2022 after selling out during the quarter.
  • Hightower 6M Holding sold 8,670 NeoGenomics shares in Q1 2022, an estimated $296K.
  • Hightower 6M Holding first reported a position in NeoGenomics in Q3 2021 and held it in 2 quarters.
  • Hightower 6M Holding's NeoGenomics position peaked at $432K in Q3 2021.
  • 278 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2022.

Based on Hightower 6M Holding's 13F filing for Q1 2022, filed 10 May 2022.